Austin-founded animal cloning company acquired by Colossal Biosciences

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.
Observer

Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts

Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and conservation.

Colossal Biosciences Update: Lab That Brought Back Dire Wolf Buys Pet-Cloning Company

Colossal Biosciences, the Dallas-based biotechnology company known for its bold mission to resurrect extinct species such as the woolly mammoth and the dodo, announced its first-ever acquisition today: ViaGen Pets & Equine,

Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning

Colossal Biosciences, the world’s de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen provides genetic preservation and cloning services for pets,

Did Tom Brady clone his dog? Explaining the process by which NFL legend duplicated his furry friend

The legendary QB cloned his dog, Lua, who passed away in 2023. Here’s more on the process, specifics and the legality of the situation.

Colossal Biosciences acquires Austin-based company, Viagen Pets and Equine

Colossal Bioscences acquired Austin-based company, Viagen Pets and Equine, “the global leader and expert in animal cloning.”
Feedback